730 related articles for article (PubMed ID: 18930554)
1. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
[TBL] [Abstract][Full Text] [Related]
2. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
[TBL] [Abstract][Full Text] [Related]
3. Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease.
Suelves AM; Arcinue CA; González-Martín JM; Kruh JN; Foster CS
Ophthalmology; 2013 Jun; 120(6):1201-9. PubMed ID: 23601800
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
Saw VP; Dart JK; Rauz S; Ramsay A; Bunce C; Xing W; Maddison PG; Phillips M
Ophthalmology; 2008 Feb; 115(2):253-261.e1. PubMed ID: 17655931
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate therapy for ocular cicatricial pemphigoid.
McCluskey P; Chang JH; Singh R; Wakefield D
Ophthalmology; 2004 Apr; 111(4):796-801. PubMed ID: 15051215
[TBL] [Abstract][Full Text] [Related]
6. Disease Relapse After Drug-Free Remission in Ocular Mucous Membrane Pemphigoid.
Shifera AS; Hong GH; Khan IR; Okeagu C; Thorne JE
Am J Ophthalmol; 2021 Mar; 223():21-27. PubMed ID: 32976845
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide for ocular inflammatory diseases.
Pujari SS; Kempen JH; Newcomb CW; Gangaputra S; Daniel E; Suhler EB; Thorne JE; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Foster CS
Ophthalmology; 2010 Feb; 117(2):356-65. PubMed ID: 19969366
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of mucous membrane pemphigoid with ocular involvement in young patients.
Rauz S; Maddison PG; Dart JK
Ophthalmology; 2005 Jul; 112(7):1268-74. PubMed ID: 15921743
[TBL] [Abstract][Full Text] [Related]
9. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
Koldingsnes W; Nossent JC
J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostics and pharmacological treatment of ocular cicatrical pemphigoid].
Brydak-Godowska J; Moneta-Wielgoś J; Pauk-Domańska M; Dróbecka-Brydak E; Samsel A; Kecik M; Kowalewski C; Mackiewicz W; Kecik D
Klin Oczna; 2005; 107(10-12):725-7. PubMed ID: 16619831
[TBL] [Abstract][Full Text] [Related]
11. Ocular cicatricial pemphigoid: case report.
Louie TD
J Am Optom Assoc; 1998 Mar; 69(3):153-60. PubMed ID: 9553330
[TBL] [Abstract][Full Text] [Related]
12. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report.
Foster CS; Chang PY; Ahmed AR
Ophthalmology; 2010 May; 117(5):861-9. PubMed ID: 20045562
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
14. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS
Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
[TBL] [Abstract][Full Text] [Related]
16. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
Ponticelli C; Villa M; Banfi G; Cesana B; Pozzi C; Pani A; Passerini P; Farina M; Grassi C; Baroli A
Am J Kidney Dis; 1999 Oct; 34(4):618-25. PubMed ID: 10516340
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil therapy for inflammatory eye disease.
Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
Sami N; Letko E; Androudi S; Daoud Y; Foster CS; Ahmed AR
Ophthalmology; 2004 Jul; 111(7):1380-2. PubMed ID: 15234140
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
